Concepedia
Statistics
Publications
7
Citations
369
H-Index
Active since
2002
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
National Institute of Health Sciences
National Center for Toxicological Research
United States Food and Drug Administration
Hans‐Jörg Martus is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and genetics.
Top concepts
MedicineGeneticsToxicologyPharmacologyMolecular BiologyGenetic EngineeringHealthGenomicsDna DamageEngineering
Publications per year
2002–2022
In vivo transgenic mutation assays
Véronique Thybaud, S.W. Dean, Takehiko Nohmi et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2003 · 146 citations
Transgenic Technology, Genetics, Genetic Engineering +4
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
Masamitu Honma, Andreas Czich, Marilyn J. Aardema et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2010 · 105 citations
Vivo Genotoxicity Assessment, Preclinical Drug Evaluation, Acute Tests +8
Genotoxicity assessment of the antiepileptic drug AMP397, an Ames-positive aromatic nitro compound
Willi Suter, Andreas Hartmann, Franziska Poetter et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2002 · 36 citations
Genotoxicity Assessment, Psychoactive Drug, Medicine +7
Gamma‐H2AX immunofluorescence for the detection of tissue‐specific genotoxicity <i>in vivo</i>
Ulla Plappert‐Helbig, Silvana Libertini, Wilfried Frieauff et al. · Environmental and Molecular Mutagenesis · 2018 · 31 citations · Full text
Identification of marker genes to monitor residual iPSCs in iPSC-derived products
Myriam Lemmens, Juliane Perner, Leon Potgeter et al. · Cytotherapy · 2022 · 21 citations
Ipsc-derived Products, Engineering, Gene Sequence Annotation +14
1–5 of 7